Li J Y, Gu H H, Zheng S J, Zha Z S, Hua M X, Jiang J J, Cai B, Zhou L, Jia Y, Fang C P, Qian B H
Department of Transfusion Medicine, Changhai Hospital, PLA Research and Innovation Base of Pediatric Hemolytic Anemia, Shanghai 200433, China.
Zhonghua Xue Ye Xue Za Zhi. 2016 Jun 14;37(6):512-6. doi: 10.3760/cma.j.issn.0253-2727.2016.06.014.
Study on the application of the systematic analysis strategies of etiology in final and differential diagnosis of hereditary hemolytic anemia (HHA).
Analysis of 1 506 patients with suspected hemolytic anemia (HA) in systematic hemolytic etiological analysis.
①1 413(94%) of the total 1 506 patients [male 799, female 707, median age 22-year-old (4 days to 86-year-old) ]were caused by membranopathy, hemoglobinopathy and enzymopathy, documented the three major causes of HHA. 369 cases (26%) of the 1 413 patients showed complex type of HA, which had the coexistence of two or more hereditary defects concerning HA in red cells, the other 1 044 cases (74%) were HA with single hemolytic cause. ②In 1 044 cases of single HA, hemoglobinopathy, membranopathy and enzymopathy was 22%, 63% and 15%, respectively. When single HA plused complex HA, the hemoglobinopathy, membranopathy and enzymopathy was 29%, 57% and 14% respectively. The difference was not statistically significant (P >0.05). ③ The most common double heterozygosis with different genetic defects was hemoglobinopathy complicated with membranopathy (50%, 184/369). The complex HA was also found in patients with the enzymopathy complicated with membranopathy (18%, 66/369) and with hemoglobinopathy (4%, 13/369). Some of complex HA patients had the same kinds of genetic defects which means double hemoglobinopathies (29 cases, 8% ), membranopathies (57 cases, 15% ) and enzymopathies (9 cases, 2%). Other kinds (11 cases, 3%) of complex HA, anemia and jaundice were seen in HAA patients accompanied with acquired and secondary defects or other system abnormalities.
The parallel etiologic examination of three major genetic hemolytic diseases can be 94% of patients for classification. The results showed that the first cause of HAA was membranopathy, second hemoglobinopathy and then enzymopathy. Complex hemolysis is not uncommon and single factor analysis alone is not enough to provide scientific basis for diagnosis.
探讨病因系统分析策略在遗传性溶血性贫血(HHA)最终诊断及鉴别诊断中的应用。
对1506例疑似溶血性贫血(HA)患者进行系统性溶血病因分析。
①1506例患者中[男性799例,女性707例,中位年龄22岁(4天至86岁)],1413例(94%)由膜病、血红蛋白病和酶病引起,记录了HHA的三大病因。1413例患者中369例(26%)表现为复杂型HA,即红细胞中存在两种或更多与HA相关的遗传性缺陷并存,另外1044例(74%)为单一溶血病因的HA。②在1044例单一HA中,血红蛋白病、膜病和酶病分别占22%、63%和15%。当单一HA加上复杂型HA时,血红蛋白病、膜病和酶病分别占29%、57%和14%。差异无统计学意义(P>0.05)。③最常见的不同遗传缺陷双重杂合子是血红蛋白病合并膜病(50%,184/369)。在酶病合并膜病(18%,66/369)和酶病合并血红蛋白病(4%,13/369)的患者中也发现了复杂型HA。一些复杂型HA患者存在相同类型的遗传缺陷,即双重血红蛋白病(29例,8%)、双重膜病(57例,15%)和双重酶病(9例,2%)。其他类型(11例,3%)的复杂型HA,在伴有获得性和继发性缺陷或其他系统异常的HAA患者中可见贫血和黄疸。
对三种主要遗传性溶血性疾病进行平行病因检查可对94%的患者进行分类。结果显示,HAA的首要病因是膜病,其次是血红蛋白病,然后是酶病。复杂溶血并不少见,仅进行单因素分析不足以提供科学的诊断依据。